{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:19:38Z","timestamp":1790882378568,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"29","license":[{"start":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T00:00:00Z","timestamp":1524614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1038\/s41388-018-0147-x","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T07:31:19Z","timestamp":1524468679000},"page":"3998-4012","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Lymphomas driven by Epstein\u2013Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2"],"prefix":"10.1038","volume":"37","author":[{"given":"Sana","family":"AlQarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazeed","family":"Al-Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Drotar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Hannigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelagh","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Herzyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kossenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2049-0863","authenticated-orcid":false,"given":"Kate","family":"Armfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarca","family":"Bailo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Tsimbouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4715-2530","authenticated-orcid":false,"given":"Joanna B.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,25]]},"reference":[{"key":"147_CR1","doi-asserted-by":"publisher","first-page":"10425","DOI":"10.1128\/JVI.05293-11","volume":"85","author":"N Sivachandran","year":"2011","unstructured":"Sivachandran N, Thawe NN, Frappier L. Epstein-Barr virus nuclear antigen 1 replication and segregation functions in nasopharyngeal carcinoma cell lines. J Virol. 2011;85:10425\u201330.","journal-title":"J Virol"},{"key":"147_CR2","doi-asserted-by":"publisher","first-page":"22421","DOI":"10.1073\/pnas.0911676106","volume":"106","author":"A Canaan","year":"2009","unstructured":"Canaan A, Haviv I, Urban AE, Schulz VP, Hartman S, Zhang Z, et al. EBNA1 regulates cellular gene expression by binding cellular promoters. Proc Natl Acad Sci USA. 2009;106:22421\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"147_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1099\/jgv.0.000681","volume":"98","author":"T Deschamps","year":"2017","unstructured":"Deschamps T, Quentin B, Leske DM, MacLeod R, Mompelat D, Tafforeau L. Epstein-Barr Virus Nuclear Antigen 1 aEBNA1a interacts with Regulator of Chromosome Condensation aRCC1a dynamically throughout the cell cycle. J Gen Virol. 2017;98:251\u2013265.","journal-title":"J Gen Virol"},{"key":"147_CR4","doi-asserted-by":"publisher","first-page":"6999","DOI":"10.1128\/JVI.00194-12","volume":"86","author":"N Malik-Soni","year":"2012","unstructured":"Malik-Soni N, Frappier L. Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections. J Virol. 2012;86:6999\u20137002.","journal-title":"J Virol"},{"key":"147_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02282-w","volume":"8","author":"SV Gnanasundram","year":"2017","unstructured":"Gnanasundram SV, Pyndiah S, Daskalogianni C, Armfield K, Nylander K, Wilson JB, F\u00e5hraeus R. PI3K\u03b4 activates E2F1 synthesis in response to mRNA translation stress. Nat Commun. 2017;8:2103. in press","journal-title":"Nat Commun"},{"key":"147_CR6","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1002\/j.1460-2075.1996.tb00674.x","volume":"15","author":"JB Wilson","year":"1996","unstructured":"Wilson JB, Bell JL, Levine AJ. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 1996;15:3117\u201326.","journal-title":"EMBO J"},{"key":"147_CR7","doi-asserted-by":"publisher","first-page":"14269","DOI":"10.1073\/pnas.2336099100","volume":"100","author":"G Kennedy","year":"2003","unstructured":"Kennedy G, Komano J, Sugden B. Epstein-Barr virus provides a survival factor to Burkitt\u2019s lymphomas. Proc Natl Acad Sci USA. 2003;100:14269\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"147_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.molcel.2005.02.029","volume":"18","author":"V Saridakis","year":"2005","unstructured":"Saridakis V, Sheng Y, Sarkari F, Holowaty MN, Shire K, Nguyen T, et al. Structure of the p53 binding domain of HAUSP\/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol Cell. 2005;18:25\u201336.","journal-title":"Mol Cell"},{"key":"147_CR9","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1099\/vir.0.2008\/003392-0","volume":"89","author":"JD O\u2019Neil","year":"2008","unstructured":"O\u2019Neil JD, Owen TJ, Wood VH, Date KL, Valentine R, Chukwuma MB, et al. Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. J Gen Virol. 2008;89:2833\u201342.","journal-title":"J Gen Virol"},{"key":"147_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-241","volume":"9","author":"TJ Owen","year":"2010","unstructured":"Owen TJ, O\u2019Neil JD, Dawson CW, Hu C, Chen X, Yao Y, et al. Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors. Mol Cancer. 2010;9:241.","journal-title":"Mol Cancer"},{"key":"147_CR11","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1038\/sj.onc.1210496","volume":"26","author":"VH Wood","year":"2007","unstructured":"Wood VH, O\u2019Neil JD, Wei W, Stewart SE, Dawson CW, Young LS. Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways. Oncogene. 2007;26:4135\u201347.","journal-title":"Oncogene"},{"key":"147_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1128\/JVI.02318-15","volume":"90","author":"I Tempera","year":"2015","unstructured":"Tempera I, De Leo A, Kossenkov AV, Cesaroni M, Song H, Dawany N, et al. Identification of MEF2B, EBF1, and IL6R as direct gene targets of Epstein-Barr Virus (EBV) nuclear antigen 1 critical for EBV-infected B-lymphocyte survival. J Virol. 2015;90:345\u201355.","journal-title":"J Virol"},{"key":"147_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/ijc.11224","volume":"106","author":"ME Drotar","year":"2003","unstructured":"Drotar ME, Silva S, Barone E, Campbell D, Tsimbouri P, Jurvansu J, et al. Epstein-Barr virus nuclear antigen-1 and Myc cooperate in lymphomagenesis. International journal of cancer. J Int du Cancer. 2003;106:388\u201395.","journal-title":"J Int du Cancer"},{"key":"147_CR14","first-page":"375","volume":"182","author":"JB Wilson","year":"1992","unstructured":"Wilson JB, Levine AJ. The oncogenic potential of Epstein-Barr virus nuclear antigen 1 in transgenic mice. Curr Top Microbiol Immunol. 1992;182:375\u201384.","journal-title":"Curr Top Microbiol Immunol"},{"key":"147_CR15","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1099\/vir.0.83296-0","volume":"89","author":"P Tsimbouri","year":"2008","unstructured":"Tsimbouri P, Al-Sheikh Y, Drotar ME, Cushley W, Wilson JB. Epstein-Barr virus nuclear antigen-1 renders lymphocytes responsive to IL-2 but not IL-15 for survival. J Gen Virol. 2008;89:2821\u201332.","journal-title":"J Gen Virol"},{"key":"147_CR16","doi-asserted-by":"publisher","first-page":"5182","DOI":"10.1038\/sj.onc.1205490","volume":"21","author":"P Tsimbouri","year":"2002","unstructured":"Tsimbouri P, Drotar ME, Coy JL, Wilson JB. bcl-xL and RAG genes are induced and the response to IL-2 enhanced in E\u00b5EBNA-1 transgenic mouse lymphocytes. Oncogene. 2002;21:5182\u20137.","journal-title":"Oncogene"},{"key":"147_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nri3156","volume":"12","author":"O Boyman","year":"2012","unstructured":"Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol. 2012;12:180\u201390.","journal-title":"Nat Rev Immunol"},{"key":"147_CR18","doi-asserted-by":"publisher","first-page":"34545","DOI":"10.1074\/jbc.M109.056499","volume":"284","author":"DQ Li","year":"2009","unstructured":"Li DQ, Divijendra Natha Reddy S, Pakala SB, Wu X, Zhang Y, Rayala SK, et al. MTA1 coregulator regulates p53 stability and function. J Biol Chem. 2009;284:34545\u201352.","journal-title":"J Biol Chem"},{"key":"147_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/1947601912455323","volume":"3","author":"DR Okoro","year":"2012","unstructured":"Okoro DR, Rosso M, Bargonetti J. Splicing up mdm2 for cancer proteome diversity. Genes Cancer. 2012;3:311\u20139.","journal-title":"Genes Cancer"},{"key":"147_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/1541-7786.MCR-06-0146","volume":"5","author":"K Schuster","year":"2007","unstructured":"Schuster K, Fan L, Harris LC. MDM2 splice variants predominantly localize to the nucleoplasm mediated by a COOH-terminal nuclear localization signal. Mol Cancer Res. 2007;5:403\u201312.","journal-title":"Mol Cancer Res"},{"key":"147_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3996","volume":"4","author":"T Zheng","year":"2013","unstructured":"Zheng T, Wang J, Zhao Y, Zhang C, Lin M, Wang X, et al. Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis. Nat Commun. 2013;4:2996.","journal-title":"Nat Commun"},{"key":"147_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-94-017-9211-0_14","volume":"85","author":"M Rosso","year":"2014","unstructured":"Rosso M, Okoro DE, Bargonetti J. Splice variants of MDM2 in oncogenesis. Subcell Biochem. 2014;85:247\u201361.","journal-title":"Subcell Biochem"},{"key":"147_CR23","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1158\/1078-0432.CCR-15-1522","volume":"22","author":"KL Bill","year":"2016","unstructured":"Bill KL, Garnett J, Meaux I, Ma X, Creighton CJ, Bolshakov S, et al. SAR405838: a novel and potent inhibitor of the MDM2:p53 axis for the treatment of dedifferentiated liposarcoma. Clin Cancer Res. 2016;22:1150\u201360.","journal-title":"Clin Cancer Res"},{"key":"147_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrc3430","volume":"13","author":"M Wade","year":"2013","unstructured":"Wade M, Li YC, Wahl GM. MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat Rev Cancer. 2013;13:83\u201396.","journal-title":"Nat Rev Cancer"},{"key":"147_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ccell.2016.08.015","volume":"30","author":"L Gu","year":"2016","unstructured":"Gu L, Zhang H, Liu T, Zhou S, Du Y, Xiong J, et al. Discovery of dual inhibitors of MDM2 and XIAP for cancer treatment. Cancer Cell. 2016;30:623\u201336.","journal-title":"Cancer Cell"},{"key":"147_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100960","volume":"9","author":"H Zhang","year":"2014","unstructured":"Zhang H, Gu L, Liu T, Chiang KY, Zhou M. Inhibition of MDM2 by nilotinib contributes to cytotoxicity in both Philadelphia-positive and negative acute lymphoblastic leukemia. PLoS ONE. 2014;9:e100960.","journal-title":"PLoS ONE"},{"key":"147_CR27","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1158\/1535-7163.MCT-10-0337","volume":"9","author":"K Kojima","year":"2010","unstructured":"Kojima K, Burks JK, Arts J, Andreeff M. The novel tryptamine derivative JNJ-26854165 induces wild-type p53- and E2F1-mediated apoptosis in acute myeloid and lymphoid leukemias. Mol Cancer Ther. 2010;9:2545\u201357.","journal-title":"Mol Cancer Ther"},{"key":"147_CR28","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1038\/leu.2009.92","volume":"23","author":"B Renouf","year":"2009","unstructured":"Renouf B, Hollville E, Pujals A, Tetaud C, Garibal J, Wiels J. Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt\u2019s lymphoma cells. Leukemia. 2009;23:1557\u201363.","journal-title":"Leukemia."},{"key":"147_CR29","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.0408774102","volume":"102","author":"MS Kang","year":"2005","unstructured":"Kang MS, Lu H, Yasui T, Sharpe A, Warren H, Cahir-McFarland E, et al. Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice. Proc Natl Acad Sci USA. 2005;102:820\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"147_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrclinonc.2016.168","volume":"14","author":"A Goodman","year":"2017","unstructured":"Goodman A, Patel SP, Kurzrock R. PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas. Nat Rev Clin Oncol. 2017;14:203\u201320.","journal-title":"Nat Rev Clin Oncol"},{"key":"147_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep36171","volume":"6","author":"N Xie","year":"2016","unstructured":"Xie N, Ma L, Zhu F, Zhao W, Tian F, Yuan F, et al. Regulation of the MDM2-p53 pathway by the nucleolar protein CSIG in response to nucleolar stress. Sci Rep. 2016;6:36171.","journal-title":"Sci Rep"},{"key":"147_CR32","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.1038\/sj.onc.1208814","volume":"24","author":"Z Zhang","year":"2005","unstructured":"Zhang Z, Wang H, Li M, Rayburn ER, Agrawal S, Zhang R. Stabilization of E2F1 protein by MDM2 through the E2F1 ubiquitination pathway. Oncogene. 2005;24:7238\u201347.","journal-title":"Oncogene"},{"key":"147_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.cellsig.2010.09.003","volume":"23","author":"X Tian","year":"2011","unstructured":"Tian X, Chen Y, Hu W, Wu M. E2F1 inhibits MDM2 expression in a p53-dependent manner. Cell Signal. 2011;23:193\u2013200.","journal-title":"Cell Signal"},{"key":"147_CR34","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1158\/1541-7786.MCR-08-0418","volume":"7","author":"EL Volk","year":"2009","unstructured":"Volk EL, Fan L, Schuster K, Rehg JE, Harris LC. The MDM2-a splice variant of MDM2 alters transformation in vitro and the tumor spectrum in both Arf- and p53-null models of tumorigenesis. Mol Cancer Res. 2009;7:863\u20139.","journal-title":"Mol Cancer Res"},{"key":"147_CR35","first-page":"315","volume":"246","author":"U Zimber-Strobl","year":"1999","unstructured":"Zimber-Strobl U, Strobl L, Hofelmayr H, Kempkes B, Staege MS, Laux G, et al. EBNA2 and c-myc in B cell immortalization by Epstein-Barr virus and in the pathogenesis of Burkitt\u2019s lymphoma. Curr Top Microbiol Immunol. 1999;246:315\u201320. discussion 321","journal-title":"Curr Top Microbiol Immunol"},{"key":"147_CR36","first-page":"361","volume":"174","author":"JB Wilson","year":"2001","unstructured":"Wilson JB, Drotar ME. Considerations in generating transgenic mice. DNA, RNA, and protein extractions from tissues--rapid and effective blotting. Methods Mol Biol. 2001;174:361\u201377.","journal-title":"Methods Mol Biol"},{"key":"147_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-184","volume":"9","author":"A Hannigan","year":"2010","unstructured":"Hannigan A, Wilson JB. Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition. Mol Cancer. 2010;9:184.","journal-title":"Mol Cancer"},{"key":"147_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/14660820510035351","volume":"6","author":"F Achilli","year":"2005","unstructured":"Achilli F, Boyle S, Kieran D, Chia R, Hafezparast M, Martin JE, et al. The SOD1 transgene in the G93A mouse model of amyotrophic lateral sclerosis lies on distal mouse chromosome 12. Amyotroph Lateral Scler Other Mot Neuron Disord. 2005;6:111\u20134.","journal-title":"Amyotroph Lateral Scler Other Mot Neuron Disord"},{"key":"147_CR39","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1083\/jcb.145.6.1119","volume":"145","author":"JA Croft","year":"1999","unstructured":"Croft JA, Bridger JM, Boyle S, Perry P, Teague P, Bickmore WA. Differences in the localization and morphology of chromosomes in the human nucleus. J Cell Biol. 1999;145:1119\u201331.","journal-title":"J Cell Biol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0147-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0147-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0147-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:10:29Z","timestamp":1684617029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0147-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,25]]},"references-count":39,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["147"],"URL":"https:\/\/doi.org\/10.1038\/s41388-018-0147-x","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,25]]},"assertion":[{"value":"20 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}